Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
74 Cards in this Set
- Front
- Back
Epinephrine
|
alpha > beta 1 or beta 2
|
|
Norepinephrine
|
potent alpha 1 and Beta 2
|
|
Dopamine
|
dopamine 1 & 2, beta 1, alpha
|
|
Endogenous catecholamines
|
epi, norepi, dopamine
|
|
Synthetic catecholamines
|
isoproterenol
dobutamine fenoldopam dopexamine |
|
isoproterenol
|
beta 1 & 2
|
|
fenoldopam
|
dopamine 1
|
|
dopexamine
|
dopamine and beta 2
|
|
Synthetic non-catecholamines
|
ephedrine
mephentermine amphetamine phenylephrine methoxamine |
|
Ephredrine
|
indirect alpha & beta 1, Direct Beta 2 (20-30)
|
|
mephentermine
|
indirect alpha and beta
|
|
amphetamine
|
alpha and beta
|
|
phenylephrine
|
direct alpha 1
|
|
methoxamine
|
direct alpha 1
|
|
Selective beta 2 agonists
|
albuterol
metaproterenol bitolterol isoetharine terbutaline ritodrine |
|
alpha 2 agonists
|
clonidine 200:1
dexedetomidine 1600:1 |
|
anticholinesterase (cholingeric agonist)
N2 receptors |
carbamates
quaternary ammonium alchols organophosphates |
|
Carbonates
|
neostigmine - QA
pyridostigmine - QA physiostigmine - TA |
|
Quaternary ammonium alcohols
|
edrophonium - QA
|
|
organophosphates
|
echothiophate - TA
|
|
Anticholinergics (antimuscarinic)
|
Atropine - TA
Scoplamine - potent antisialogogue and CNS effects Glycopyrrolate - QA |
|
Sympatholytic alpha antagonists
|
Phentolamine - regitine
prazosin - minipress terazosin - Hystin Doxazosine - cardura Phenoxybenzamine - dibrazyline yohimbine |
|
Phentolamine (Regitine)
|
non-selective, blocks alpha 1 > alpha2
|
|
Prazosin (Minipress)
|
selective alpha 1 blocker
|
|
terazosin (Hytrin)
|
selective alpha 1
|
|
Doxazosine (cardura)
|
selective alpha 1
|
|
phenoxybenzamine (dibeazyline)
|
irreversible binds alpha 1 > alpha 2 no antagonism
|
|
Yohimbine
|
selective presynaptic alpha 2 blocker
|
|
Sympatholytic Beta Antagonist
|
non selective (blocks beta 1 & beta 2
|
|
sympatholytic beta antagonist
|
propranolol (inderal)
Nadolol (corgard) Timolol (timoptic) Sotalol (betapace) |
|
beta antagonist - cardioselective - blocks beta 1
large doses non-selective |
metoprolol
atenolol betaxolol esmolol |
|
Esmolol metabolism
|
hyrdrolysis by RBC esteraces
|
|
alpha & beta antagonist
|
Labetalol (normadyne)
|
|
labetalol
|
selective alpha 1 & nonselective beta
Beta : alpha blocking - 3:1 oral 7:1 IV |
|
angiotensin - converting enzyme inhibitors
|
for dec CO and inc filling pressures
|
|
ACE inhibitors
|
captopril
enalapril lisinopril ramipril |
|
angiotensin II receptor blocker
|
inhibits binding of angiotensin II to ATI receptors therefore no vasoconstriction or aldosterone secretion so no H2O and Na+ retention
|
|
angiotensin II receptor blocker (AT1)
|
Losartan (Cozaar) 2-3 fold increase in renin activity (H2O retention)
|
|
Vasodilating drugs - arteriolar dilator leads to forward flow for decreased LV output (CO)
|
hydralazine (apresoline) selectively relaxing arterial smooth muscle
Minoxidil (rogaine) |
|
Nitric Oxide Activators - venous dliator lead to increased filling pressure (preload)
|
nitroglycerin
Isosorbide- oral nitrate Inomax Nitroprusside |
|
Nitroglycerin
|
organic nitrate - incr. doses- relaxation of arterial vascular
acts on venous capacitance vessels and large coronary arteries |
|
Nitroprusside
|
direct acting non selective peripheral vasodilator
|
|
Papeverine
|
vasodilator - inhibit phosphodiesterase
|
|
Adenosine
|
endogenous potent coronary artery vasodilator
|
|
dipyridamole
|
vasodilator - selective adenosine uptate inhibitor
|
|
Calcium channel blockers
|
dec Ca+ leads to vasodilation
|
|
Diuretics
|
decreased volume, decreased preload, decreased BP
|
|
Alpha 1
|
postsynaptic
|
|
agonist
|
vasoconstriction
mydriasis relaxation GI tract contraction GI sphincters contraction bladder sphincter |
|
alpha 1 antagonist
|
vasodilation
miosis contraction of GI tract Relaxation of GI sphincters Relaxation bladder sphincter |
|
alpha 2 (postsynaptic) antagonist
|
allows NE release
|
|
Alpha 2 agonist
|
(presynaptic)
|
|
Alpha 2 (presynaptic) agonist
|
inhibit NE release
|
|
Alpha 2 (presynaptic) antagonist
|
allows NE release
|
|
Alpha 2
|
(post synaptic)
|
|
Alpha 2 (post synaptic) agonist
|
platelet aggregation
hyperpolarize CNS (sedation) |
|
Alpha 2 (post synpatic) antagonist
|
hypopolarize CNS
|
|
Beta 1
|
Post synaptic
|
|
beta 1 post synaptic agonist
|
incr. conduction (dromotrophy)
incr. automaticity incr. contractility (inotrophy) incr. HR (chronotrophy) |
|
Beta 1 post synaptice antagonist
|
decr. conduction
decr. automaticity decr contractility decreased HR |
|
beta 2
|
postsynaptic
|
|
Beta 2 postsynaptic agonist
|
vasodilation
bronchodilation gi relaxation bladder relaxation glycogenolysis lipolysis (beta 3) |
|
Beta 2 postsynaptic antagonist
|
vasoconstriction
bronchoconstriction ci contraction uterine contraction bladder contraction decr. amt of glucose (decr glycogenolysis) |
|
Dopamine 1
|
post synaptic - renal, mesentery,
coronary, cerebral |
|
Dopamine 1 (post synaptic) agonist
|
vasodilation
|
|
Dopamine 1 (post synaptic) antagonist
|
vasoconstriction
|
|
Dopamine 2
|
presynaptic
|
|
dopamine 2 presynaptic agonist
|
inhibit NE release
|
|
Dopamine 2 presynaptic antagonist
|
allows NE release
|
|
Cholinergic receptors
|
muscarinic
nicotinic 1 nicotinic 2 |
|
Cholinergic muscarinic agonist -
|
PNS response
miosis decr. HR decr. contractility vasodilation bronchocontriction incr. motility GI sphincter relaxation bladder contraction bladder sphincter relaxation incr. gland secretion |
|
Cholinergic muscarinic agonist
|
mydiasis
incr. HR incr. contractility vasoconstriction bronchodilation decr motility GI sphincter contraction bladder relaxation bladder sphincter contraction decr. gland secretion |
|
nicotinic 1
|
autonomic ganglia
blocked by ganglionic blocking agent |
|
Nicotinic 2
|
NMJ
blocked by NMB |